Fonarow GC - Search Results

1

Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.

Khan MS, Greene SJ, Hellkamp AS, DeVore AD, Shen X, Albert NM, Patterson JH, Spertus JA, Thomas LE, Williams FB, Hernandez AF, Fonarow GC, Butler J. Khan MS, et al. Among authors: fonarow gc. Circ Heart Fail. 2021 Nov;14(11):e008351. doi: 10.1161/CIRCHEARTFAILURE.121.008351. Epub 2021 Oct 22. Circ Heart Fail. 2021. PMID: 34674536

2

Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure. A positron emission tomography study.

Middlekauff HR, Nitzsche EU, Hamilton MA, Schelbert HR, Fonarow GC, Moriguchi JD, Hage A, Saleh S, Gibbs GG. Middlekauff HR, et al. Among authors: fonarow gc. Circulation. 1995 Aug 1;92(3):395-401. doi: 10.1161/01.cir.92.3.395. Circulation. 1995. PMID: 7634454

3

Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.

Steimle AE, Stevenson LW, Chelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD, Kartashov A, Tillisch JH. Steimle AE, et al. Among authors: fonarow gc. Circulation. 1997 Aug 19;96(4):1165-72. doi: 10.1161/01.cir.96.4.1165. Circulation. 1997. PMID: 9286945

4

Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure: implications for 'triggering' adverse cardiac events.

Middlekauff HR, Nguyen AH, Negrao CE, Nitzsche EU, Hoh CK, Natterson BA, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD. Middlekauff HR, et al. Among authors: fonarow gc. Circulation. 1997 Sep 16;96(6):1835-42. doi: 10.1161/01.cir.96.6.1835. Circulation. 1997. PMID: 9323069

5

Exaggerated renal vasoconstriction during exercise in heart failure patients.

Middlekauff HR, Nitzsche EU, Hoh CK, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD. Middlekauff HR, et al. Among authors: fonarow gc. Circulation. 2000 Feb 22;101(7):784-9. doi: 10.1161/01.cir.101.7.784. Circulation. 2000. PMID: 10683353 Clinical Trial.

6

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.

Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Horwich TB, et al. Among authors: fonarow gc. J Card Fail. 2002 Aug;8(4):216-24. doi: 10.1054/jcaf.2002.0804216. J Card Fail. 2002. PMID: 12397569

7

Emotional well-being of heart failure patients and their caregivers.

Evangelista LS, Dracup K, Doering L, Westlake C, Fonarow GC, Hamilton M. Evangelista LS, et al. Among authors: fonarow gc. J Card Fail. 2002 Oct;8(5):300-5. doi: 10.1054/jcaf.2002.128005. J Card Fail. 2002. PMID: 12411980

8

Heart failure: recent advances in prevention and treatment.

Fonarow GC. Fonarow GC. Rev Cardiovasc Med. 2000 Summer;1(1):25-33, 54. Rev Cardiovasc Med. 2000. PMID: 12457149 Review.

9

The impact of obesity on survival in patients with heart failure.

Horwich TB, Fonarow GC. Horwich TB, et al. Among authors: fonarow gc. Heart Fail Monit. 2002;3(1):8-14. Heart Fail Monit. 2002. PMID: 12634883 Review.

10

B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.

Fonarow GC. Fonarow GC. Heart Fail Rev. 2003 Oct;8(4):321-5. doi: 10.1023/a:1026170228469. Heart Fail Rev. 2003. PMID: 14574051 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,711 results

Search Page